209(top 1%)
papers
9.7K(top 1%)
citations
50(top 1%)
h-index
95(top 1%)
g-index
225
all documents
10.1K
doc citations
1.9K
citing journals
177
times ranked

Top Articles

#TitleJournalYearCitations
1Risks of Testosterone-Replacement Therapy and Recommendations for MonitoringNew England Journal of Medicine2004650
2BCG immunotherapy of bladder cancer: 20 years onLancet, The1999417
3A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen RangeJournal of Urology2011408
4Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent GrowthEuropean Urology2009376
5Development and Validation of an Abbreviated Version of the Expanded Prostate Cancer Index Composite Instrument for Measuring Health-related Quality of Life Among Prostate Cancer SurvivorsUrology2010356
6Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSAScience Translational Medicine2011313
7IS LOW SERUM FREE TESTOSTERONE A MARKER FOR HIGH GRADE PROSTATE CANCER?Journal of Urology2000290
8Five-year Analysis of a Multi-institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM RegistryEuropean Urology2015282
9Minimally Important Difference for the Expanded Prostate Cancer Index Composite Short FormUrology2015241
10High Failure Rate of Indwelling Ureteral Stents in Patients with Extrinsic Obstruction: Experience at 2 InstitutionsJournal of Urology1989214
11Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or lessUrology2006200
12Occult Prostate Cancer in Men With Low Serum Testosterone LevelsJAMA - Journal of the American Medical Association1996192
13Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate CancerClinical Cancer Research2009184
14Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancerUrologic Oncology: Seminars and Original Investigations2013181
15Testosterone Replacement Therapy in Hypogonadal Men at High Risk for Prostate Cancer: Results of 1 Year of Treatment in Men With Prostatic Intraepithelial NeoplasiaJournal of Urology2003173
16Results of Inferior Vena Cava Resection for Renal Cell CarcinomaJournal of Urology1981154
17Expanded Prostate Cancer Index Composite for Clinical Practice: Development and Validation of a Practical Health Related Quality of Life Instrument for Use in the Routine Clinical Care of Patients With Prostate CancerJournal of Urology2011152
18Experimental Cryptorchidism Induces Testicular Germ Cell Apoptosis by p53-Dependent and -Independent Pathways In MiceBiology of Reproduction1998136
19MR classification of renal masses with pathologic correlationEuropean Radiology2008136
20Testosterone Therapy in Men With Untreated Prostate CancerJournal of Urology2011134
21Heat stress causes testicular germ cell apoptosis in adult miceJournal of Andrology1997134
22p53-Mediated Germ Cell Quality Control in SpermatogenesisDevelopmental Biology1998129
23Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growthBritish Journal of Cancer2009121
24Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytesInfection and Immunity1994111
25[-2]Proenzyme Prostate Specific Antigen for Prostate Cancer Detection: A National Cancer Institute Early Detection Research Network Validation StudyJournal of Urology200898
26p53 and Fas Are Sequential Mechanisms of Testicular Germ Cell ApoptosisJournal of Andrology200297
27Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogensAndrologia201488
28Original Articles: Testis Cancer: A Review of Scrotal Violation in Testicular Cancer: Is Adjuvant Local Therapy Necessary?Journal of Urology199587
29IFN-α 2B Enhances Th1 Cytokine Responses in Bladder Cancer Patients Receiving Mycobacterium bovis Bacillus Calmette-Guérin ImmunotherapyJournal of Immunology199987
30Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state.Journal of Immunology199786
31Prospective Study of Determinants and Outcomes of Deferred Treatment or Watchful Waiting Among Men With Prostate Cancer in a Nationwide CohortJournal of Clinical Oncology200983
32Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancerCancer201482
33Is low serum free testosterone a marker for high grade prostate cancer?Journal of Urology200080
34IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapyJournal of Immunology199979
35Male impotenceLancet, The199975
36Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxinBiochemical and Biophysical Research Communications200375
37Role of IL-12 in the induction and potentiation of IFN-gamma in response to bacillus Calmette-GuérinJournal of Immunology199968
38Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant stateJournal of Immunology199766
39Congenital anomalies of the vas deferens, epididymis, and seminal vesiclesUrology199764
40Analysis of human immunodeficiency virus in semen: indications of a genetically distinct virus reservoirJournal of Reproductive Immunology199862
41Measuring and Predicting Prostate Cancer Related Quality of Life Changes Using EPIC for Clinical PracticeJournal of Urology201462
42ORIGINAL RESEARCH—ENDOCRINOLOGY: Wide Variability in Laboratory Reference Values for Serum TestosteroneJournal of Sexual Medicine200661
43Role of IL-12 in the Induction and Potentiation of IFN-γ in Response to Bacillus Calmette-GuérinJournal of Immunology199961
44Defective NKT Cell Activation by CD1d+ TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-GalactosylceramidePLoS ONE201057
45Measuring patients’ expectations regarding health-related quality-of-life outcomes associated with prostate cancer surgery or radiotherapyUrology200655
46Classics of Urology: A Half Century History of the Most Frequently Cited Articles (1955-2009)Urology201054
47Comparing Costs of Robotic, Laparoscopic, and Open Partial NephrectomyJournal of Endourology201354
48Validation in a Multiple Urology Practice Cohort of the Prostate Cancer Prevention Trial Calculator for Predicting Prostate Cancer DetectionJournal of Urology200952
49Influence of Testicular Carcinoma on Ipsilateral SpermatogenesisJournal of Urology199251
50Synchronous Adenocarcinoma and Transitional Cell Carcinoma of the Bladder Associated with Augmentation: Case Report And Review of the LiteratureJournal of Urology199351